145 results on '"Yamamoto, Yoshiya"'
Search Results
2. Prognostic effect of a vasopressin V2 receptor antagonist in acute congestive heart failure patients with hypoperfusion, the wet–cold pattern
3. Coronary orbital atherectomy using a five-French guiding catheter
4. Very urgent endoscopic retrograde cholangiopancreatography is associated with early
5. Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication
6. Impact of dedicated hemostasis device for distal radial arterial access with an adequate hemostasis protocol on radial arterial observation by ultrasound
7. Effects of high-speed rotational atherectomy in peripheral artery disease patients with calcified lesions: a retrospective multicenter registry
8. Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection
9. Safety and efficacy of elbasvir and grazoprevir in Japanese hemodialysis patients with genotype 1b hepatitis C virus infection
10. Concomitant singularities of Yb-valence and magnetism at a critical lattice parameter of icosahedral quasicrystals and approximants
11. Usefulness of the Direct and/or Total Bilirubin to Predict Adverse Outcomes in Patients With Acute Decompensated Heart Failure
12. Delay in seeking treatment before emergent heart failure readmission and its association with clinical phenotype
13. Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in Japan
14. Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy
15. Detailed Observation of Fish Tapeworm Using Colonoscopy
16. Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure
17. Efficacy and prognosis of antiviral therapy on hepatitis C following treatment of lymphoma in HCV-positive diffuse large-cell lymphoma
18. A Phase I Study of Combination Therapy with Sorafenib and 5-Fluorouracil in Patients with Advanced Hepatocellular Carcinoma
19. Association between the body mass index and the clinical findings in patients with acute heart failure: evaluation of the obesity paradox in patients with severely decompensated acute heart failure
20. Are atherosclerotic risk factors associated with a poor prognosis in patients with hyperuricemic acute heart failure? The evaluation of the causal dependence of acute heart failure and hyperuricemia
21. Add‐on effects of fluvastatin in simeprevir/pegylated‐interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study
22. Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus‐infected patients with renal impairment
23. Effects of activation of an alcohol metabolic gene, cigarette smoking, and alcohol intake on the incidence of metachronous gastric cancer in patients who underwent endoscopic resection for gastric cancer: A multicenter retrospective pilot study.
24. Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
25. Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis.
26. Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C.
27. Seasonal variation in patients with acute heart failure: prognostic impact of admission in the summer
28. Prognostic impact of the serum heart-type fatty acid-binding protein (H-FABP) levels in patients admitted to the non-surgical intensive care unit
29. Intracardiac echocardiography to diagnose pannus formation after aortic valve replacement
30. Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions
31. Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.
32. The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma
33. Pressure-induced transitions in R Co5 (R = Y, La) studied by x-ray emission spectroscopy, x-ray diffraction and density functional theory.
34. Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B.
35. Efficacy of therapy for advanced hepatocellular carcinoma: Intra-arterial 5-fluorouracil and subcutaneous interferon with image-guided radiation
36. Prevalence of Mutations in Core Promoter/Precore Region in Japanese Patients with Chronic Hepatitis B Virus Infection
37. Prevention of hepatitis B virus reactivation under rituximab therapy
38. Genomic profiling of intestinal/mixed‐type superficial non‐ampullary duodenal epithelial tumors.
39. Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.
40. Possible involvement of tetraspanin CO-029 in hematogenous intrahepatic metastasis of liver cancer cells
41. Electronic and crystal structures of LnFeAsO1−xHx (Ln = La, Sm) studied by x-ray absorption spectroscopy, x-ray emission spectroscopy, and x-ray diffraction: II pressure dependence.
42. Electronic and crystal structures of LnFeAsO1−xHx (Ln = La, Sm) studied by x-ray absorption spectroscopy, x-ray emission spectroscopy, and x-ray diffraction (part I: carrier-doping dependence).
43. Tenofovir–disoproxil–fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection.
44. Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.
45. Long‐term outcomes and risk factors of recurrent biliary obstruction after permanent endoscopic biliary stenting for choledocholithiasis in high‐risk patients.
46. Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting.
47. Mössbauer Spectroscopy Study of KxFe2−ySe2 under Pressure.
48. Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis.
49. Younger‐ vs Older‐Old Patients with Heart Failure with Preserved Ejection Fraction.
50. Successful direct clipping of the bleeding source of a colonic diverticular hemorrhage using the "long-hood gel-filling" method.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.